|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 376 for Ube3a

<< First    < Previous  |  Next >    Last >>
0.049s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: Homo sapiens
Gene
Type: gene
Organism: Drosophila melanogaster
Gene
Type: gene
Organism: Rattus norvegicus
Gene
Type: gene
Organism: Danio rerio
Protein Domain
Type: Family
Description: UBE3A (also known as E6-AP) is an E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. It regulates cell proliferation by promoting proteasomal degradation of p27 []. It can also serve as a molecular circadian clock through regulating the BMAL1 transcription factor [].
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Publication
First Author: Gossan NC
Year: 2014
Journal: Nucleic Acids Res
Title: The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor.
Volume: 42
Issue: 9
Pages: 5765-75
Publication
First Author: Burette AC
Year: 2017
Journal: J Comp Neurol
Title: Subcellular organization of UBE3A in neurons.
Volume: 525
Issue: 2
Pages: 233-251
Publication
First Author: Mishra A
Year: 2009
Journal: Neurobiol Dis
Title: UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27.
Volume: 36
Issue: 1
Pages: 26-34
Protein
Organism: Mus musculus
Length: 870  
Fragment?: false
Protein
Organism: Mus musculus
Length: 906  
Fragment?: true
Publication
First Author: Jordan C
Year: 2006
Journal: Hum Mol Genet
Title: Ube3a expression is not altered in Mecp2 mutant mice.
Volume: 15
Issue: 14
Pages: 2210-5
Publication
First Author: Shi SQ
Year: 2015
Journal: Curr Biol
Title: Ube3a imprinting impairs circadian robustness in Angelman syndrome models.
Volume: 25
Issue: 5
Pages: 537-45
Publication
First Author: Miura K
Year: 2002
Journal: Neurobiol Dis
Title: Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.
Volume: 9
Issue: 2
Pages: 149-59
Publication
First Author: Yashiro K
Year: 2009
Journal: Nat Neurosci
Title: Ube3a is required for experience-dependent maturation of the neocortex.
Volume: 12
Issue: 6
Pages: 777-83
Publication      
First Author: Elgersma Y
Year: 2018
Journal: MGI Direct Data Submission
Title: Alleles of Ube3a
Publication
First Author: Sen D
Year: 2021
Journal: Sci Rep
Title: Evaluation of UBE3A antibodies in mice and human cerebral organoids.
Volume: 11
Issue: 1
Pages: 6323
Publication
First Author: Furumai R
Year: 2019
Journal: Hum Mol Genet
Title: UBE3A regulates the transcription of IRF, an antiviral immunity.
Volume: 28
Issue: 12
Pages: 1947-1958
Publication
First Author: Colas D
Year: 2005
Journal: Neurobiol Dis
Title: Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
Volume: 20
Issue: 2
Pages: 471-8
Publication
First Author: Huang HS
Year: 2011
Journal: Nature
Title: Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons.
Volume: 481
Issue: 7380
Pages: 185-9
Publication
First Author: Gu B
Year: 2019
Journal: J Clin Invest
Title: Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.
Volume: 129
Issue: 1
Pages: 163-168
Publication
First Author: Smith SE
Year: 2011
Journal: Sci Transl Med
Title: Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice.
Volume: 3
Issue: 103
Pages: 103ra97
Publication
First Author: Avagliano Trezza R
Year: 2021
Journal: Sci Rep
Title: Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function.
Volume: 11
Issue: 1
Pages: 3007
Publication
First Author: Meng L
Year: 2013
Journal: PLoS Genet
Title: Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.
Volume: 9
Issue: 12
Pages: e1004039
Publication
First Author: Avagliano Trezza R
Year: 2019
Journal: Nat Neurosci
Title: Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.
Volume: 22
Issue: 8
Pages: 1235-1247
Publication
First Author: Copping NA
Year: 2017
Journal: Hum Mol Genet
Title: Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.
Volume: 26
Issue: 20
Pages: 3995-4010
Publication
First Author: Wallace ML
Year: 2012
Journal: Neuron
Title: Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects.
Volume: 74
Issue: 5
Pages: 793-800
Publication
First Author: Krishnan V
Year: 2017
Journal: Nature
Title: Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1.
Volume: 543
Issue: 7646
Pages: 507-512
Publication  
First Author: Sonzogni M
Year: 2019
Journal: Mol Autism
Title: Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
Volume: 10
Pages: 23
Publication  
First Author: Hillman PR
Year: 2017
Journal: Epigenetics Chromatin
Title: Genomic imprinting does not reduce the dosage of UBE3A in neurons.
Volume: 10
Pages: 27
Publication
First Author: Born HA
Year: 2017
Journal: Sci Rep
Title: Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice.
Volume: 7
Issue: 1
Pages: 8451
Publication
First Author: Sun J
Year: 2020
Journal: Sci Rep
Title: PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome.
Volume: 10
Issue: 1
Pages: 9824
Publication
First Author: Greer PL
Year: 2010
Journal: Cell
Title: The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
Volume: 140
Issue: 5
Pages: 704-16
Publication
First Author: Ehlen JC
Year: 2015
Journal: J Neurosci
Title: Maternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact.
Volume: 35
Issue: 40
Pages: 13587-98
Publication
First Author: Su H
Year: 2011
Journal: Neurosci Lett
Title: Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome.
Volume: 487
Issue: 2
Pages: 129-33
Publication  
First Author: Schmid RS
Year: 2021
Journal: J Clin Invest
Title: CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.
Volume: 131
Issue: 5
Publication
First Author: Maheshwari M
Year: 2014
Journal: Hum Mol Genet
Title: Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology.
Volume: 23
Issue: 23
Pages: 6235-45
Publication
First Author: Gustin RM
Year: 2010
Journal: Neurobiol Dis
Title: Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
Volume: 39
Issue: 3
Pages: 283-91
Publication  
First Author: Lawson-Yuen A
Year: 2007
Journal: Brain Res
Title: Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice.
Volume: 1180
Pages: 1-6
Publication
First Author: Sun J
Year: 2015
Journal: Cell Rep
Title: UBE3A Regulates Synaptic Plasticity and Learning and Memory by Controlling SK2 Channel Endocytosis.
Volume: 12
Issue: 3
Pages: 449-61
Publication
First Author: Silva-Santos S
Year: 2015
Journal: J Clin Invest
Title: Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
Volume: 125
Issue: 5
Pages: 2069-76
Publication
First Author: Reiter LT
Year: 2006
Journal: Hum Mol Genet
Title: Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
Volume: 15
Issue: 18
Pages: 2825-35
Publication
First Author: Singh BK
Year: 2017
Journal: Hum Mol Genet
Title: Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Volume: 26
Issue: 20
Pages: 4042-4054
Publication  
First Author: Milazzo C
Year: 2021
Journal: JCI Insight
Title: Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model.
Volume: 6
Issue: 15
Publication
First Author: Judson MC
Year: 2014
Journal: J Comp Neurol
Title: Allelic specificity of Ube3a expression in the mouse brain during postnatal development.
Volume: 522
Issue: 8
Pages: 1874-96
Publication
First Author: Landers M
Year: 2005
Journal: Nucleic Acids Res
Title: Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans.
Volume: 33
Issue: 13
Pages: 3976-84
Publication
First Author: Zampeta FI
Year: 2020
Journal: Hum Mol Genet
Title: Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms.
Volume: 29
Issue: 18
Pages: 3032-3043
Publication
First Author: Miao S
Year: 2013
Journal: J Neurosci
Title: The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons.
Volume: 33
Issue: 1
Pages: 327-33
Publication
First Author: Mardirossian S
Year: 2009
Journal: Exp Neurol
Title: Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
Volume: 220
Issue: 2
Pages: 341-8
Publication
First Author: Judson MC
Year: 2016
Journal: Neuron
Title: GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.
Volume: 90
Issue: 1
Pages: 56-69
Publication
First Author: Kim H
Year: 2016
Journal: J Neurosci
Title: Maternal Loss of Ube3a Impairs Experience-Driven Dendritic Spine Maintenance in the Developing Visual Cortex.
Volume: 36
Issue: 17
Pages: 4888-94
Publication
First Author: Tsai TF
Year: 1999
Journal: Hum Mol Genet
Title: Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome.
Volume: 8
Issue: 8
Pages: 1357-64
Publication
First Author: Maheshwari M
Year: 2012
Journal: J Biol Chem
Title: Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.
Volume: 287
Issue: 35
Pages: 29949-57
Publication
First Author: Jiang YH
Year: 2010
Journal: PLoS One
Title: Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
Volume: 5
Issue: 8
Pages: e12278
Publication
First Author: Sonzogni M
Year: 2020
Journal: Mol Autism
Title: Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
Volume: 11
Issue: 1
Pages: 70
GXD Expression    
Probe: MGI:6186230
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:6191529
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Ube3a
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6186230
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689421
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:6191529
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Ube3a
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6186230
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689426
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:6191529
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Ube3a
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:6186230
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6191529
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Ube3a
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:6186230
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6191529
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Ube3a
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:6186230
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689424
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6191529
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Ube3a
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6186230
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6191529
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Ube3a
Detected: true
Specimen Num: 6
Publication
First Author: Chamberlain SJ
Year: 2001
Journal: Genomics
Title: The Prader-Willi syndrome imprinting center activates the paternally expressed murine Ube3a antisense transcript but represses paternal Ube3a.
Volume: 73
Issue: 3
Pages: 316-22
Publication
First Author: Landers M
Year: 2004
Journal: Nucleic Acids Res
Title: Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn.
Volume: 32
Issue: 11
Pages: 3480-92
Publication  
First Author: Berrios J
Year: 2016
Journal: Nat Commun
Title: Loss of UBE3A from TH-expressing neurons suppresses GABA co-release and enhances VTA-NAc optical self-stimulation.
Volume: 7
Pages: 10702
Publication  
First Author: Musi CA
Year: 2020
Journal: Neurobiol Dis
Title: JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
Volume: 140
Pages: 104812
Publication
First Author: Grier MD
Year: 2015
Journal: PLoS One
Title: Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells.
Volume: 10
Issue: 4
Pages: e0124649
Publication
First Author: Pignatelli M
Year: 2014
Journal: J Neurosci
Title: Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome.
Volume: 34
Issue: 13
Pages: 4558-66
Publication
First Author: Wallace ML
Year: 2017
Journal: J Neurophysiol
Title: Ube3a loss increases excitability and blunts orientation tuning in the visual cortex of Angelman syndrome model mice.
Volume: 118
Issue: 1
Pages: 634-646
Publication
First Author: Rotaru DC
Year: 2018
Journal: J Neurosci
Title: Adult Ube3a Gene Reinstatement Restores the Electrophysiological Deficits of Prefrontal Cortex Layer 5 Neurons in a Mouse Model of Angelman Syndrome.
Volume: 38
Issue: 37
Pages: 8011-8030
Publication
First Author: Khatri N
Year: 2018
Journal: J Neurosci
Title: The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization.
Volume: 38
Issue: 2
Pages: 363-378
Publication
First Author: Cheron G
Year: 2005
Journal: Neuroscience
Title: Fast cerebellar oscillation associated with ataxia in a mouse model of Angelman syndrome.
Volume: 130
Issue: 3
Pages: 631-7
Publication  
First Author: Olabarria M
Year: 2019
Journal: Commun Biol
Title: Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer's disease.
Volume: 2
Pages: 111
Publication
First Author: Jiang YH
Year: 1998
Journal: Neuron
Title: Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.
Volume: 21
Issue: 4
Pages: 799-811
Publication
First Author: Mulherkar SA
Year: 2010
Journal: Neurobiol Dis
Title: Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
Volume: 40
Issue: 3
Pages: 586-92
Publication
First Author: Egawa K
Year: 2012
Journal: Sci Transl Med
Title: Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome.
Volume: 4
Issue: 163
Pages: 163ra157
Publication
First Author: Sutcliffe JS
Year: 1997
Journal: Genome Res
Title: The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.
Volume: 7
Issue: 4
Pages: 368-77
Publication  
First Author: Wang T
Year: 2017
Journal: Front Cell Neurosci
Title: Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome.
Volume: 11
Pages: 418
Publication
First Author: Dindot SV
Year: 2008
Journal: Hum Mol Genet
Title: The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Volume: 17
Issue: 1
Pages: 111-8
Publication  
First Author: Grier MD
Year: 2015
Journal: Behav Brain Res
Title: Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences.
Volume: 291
Pages: 260-7
Publication  
First Author: Llewellyn KJ
Year: 2015
Journal: Neurobiol Dis
Title: Administration of CoQ10 analogue ameliorates dysfunction of the mitochondrial respiratory chain in a mouse model of Angelman syndrome.
Volume: 76
Pages: 77-86
Publication  
First Author: Kumar V
Year: 2019
Journal: Front Mol Neurosci
Title: Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse.
Volume: 12
Pages: 289
Publication  
First Author: Huang HS
Year: 2013
Journal: Behav Brain Res
Title: Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.
Volume: 243
Pages: 79-90
Publication
First Author: Meng L
Year: 2015
Journal: Nature
Title: Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
Volume: 518
Issue: 7539
Pages: 409-12
Publication  
First Author: Jamal I
Year: 2017
Journal: Neurobiol Dis
Title: Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome.
Volume: 105
Pages: 99-108
Publication
First Author: Godavarthi SK
Year: 2015
Journal: Biochem Biophys Res Commun
Title: Impaired adult hippocampal neurogenesis and its partial reversal by chronic treatment of fluoxetine in a mouse model of Angelman syndrome.
Volume: 464
Issue: 4
Pages: 1196-201
Publication  
First Author: Panov J
Year: 2021
Journal: Neurobiol Dis
Title: Bioinformatics analyses show dysregulation of calcium-related genes in Angelman syndrome mouse model.
Volume: 148
Pages: 105180
Publication
First Author: Condon KH
Year: 2013
Journal: J Neurosci
Title: The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.
Volume: 33
Issue: 9
Pages: 3799-814
Publication  
First Author: Dutta R
Year: 2020
Journal: Neuroscience
Title: Behavioral Evaluation of Angelman Syndrome Mice at Older Ages.
Volume: 445
Pages: 163-171
Publication
First Author: Kaphzan H
Year: 2011
Journal: J Neurosci
Title: Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome.
Volume: 31
Issue: 48
Pages: 17637-48
Publication
First Author: Sato M
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a.
Volume: 107
Issue: 12
Pages: 5611-6
Publication
First Author: Farook MF
Year: 2012
Journal: PLoS One
Title: Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models.
Volume: 7
Issue: 8
Pages: e43030
Publication
First Author: Kaphzan H
Year: 2012
Journal: Biol Psychiatry
Title: Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors.
Volume: 72
Issue: 3
Pages: 182-90
Publication  
First Author: Stoppel DC
Year: 2017
Journal: Exp Neurol
Title: Hypersociability in the Angelman syndrome mouse model.
Volume: 293
Pages: 137-143
Publication
First Author: Riday TT
Year: 2012
Journal: J Clin Invest
Title: Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.
Volume: 122
Issue: 12
Pages: 4544-54
Publication
First Author: Godavarthi SK
Year: 2014
Journal: J Neurochem
Title: Reversal of reduced parvalbumin neurons in hippocampus and amygdala of Angelman syndrome model mice by chronic treatment of fluoxetine.
Volume: 130
Issue: 3
Pages: 444-54
Publication
First Author: Wolter JM
Year: 2020
Journal: Nature
Title: Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA.
Volume: 587
Issue: 7833
Pages: 281-284
Publication
First Author: Godavarthi SK
Year: 2012
Journal: Hum Mol Genet
Title: Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
Volume: 21
Issue: 8
Pages: 1824-34
Publication
First Author: Bhat KP
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.
Volume: 111
Issue: 15
Pages: 5706-11
Publication
First Author: Judson MC
Year: 2017
Journal: J Neurosci
Title: Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.
Volume: 37
Issue: 31
Pages: 7347-7361